Others titles
- HIV AIDS Incidence Prevalence and Mortality
- Estimated HIV Incidence Prevalence and Mortality Rates
Keywords
- HIV AIDS Incidence
- Global HIV Incidence
- HIV Prevalence
- Antiretroviral Therapy
HIV Incidence Prevalence and Mortality

The Global Burden of Disease Study 2015 (GBD 2015), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors globally, for 21 regions, and for 195 countries and territories. This dataset was also published in The Lancet in July 2016 in “Global, regional, and national incidence, prevalence, and mortality for HIV, 1980-2015: estimates from the Global Burden of Disease Study 2015.”
Get The Data
- Research
Non-Commercial,
Share-Alike,
Attribution Free Forever
- Commercial
Commercial Use,
Remix & Adapt,
White Label Log in to download
Description
The dataset include estimates of antiretroviral therapy (ART) coverage for 2015 and HIV-specific mortality for patients on ART. For countries without high-quality vital registration data, the estimated prevalence and incidence with data from antenatal care clinics and population-based seroprevalence surveys, and with assumptions by age and sex on initial CD4 distribution at infection, CD4 progression rates (probability of progression from higher to lower CD4 cell-count category), on and off antiretroviral therapy (ART) mortality, and mortality from all other causes. The estimation strategy links the GBD 2015 assessment of all-cause mortality and estimation of incidence and prevalence so that for each draw from the uncertainty distribution all assumptions used in each step are internally consistent.
The estimated incidence, prevalence, and death with GBD versions of the Estimation and Projection Package (EPP) and Spectrum software originally developed by the Joint United Nations Programme on HIV/AIDS (UNAIDS). An open-source version of EPP was used and recoded Spectrum for speed, and used updated assumptions from systematic reviews of the literature and GBD demographic data. For countries with high-quality vital registration data, the cohort incidence bias adjustment model was developed to estimate HIV incidence and prevalence largely from the number of deaths caused by HIV recorded in cause-of-death statistics. The statistics for garbage coding and HIV misclassification was corrected.
About this Dataset
Data Info
Date Created | 1980-01 |
---|---|
Last Modified | 2016-11-08 |
Version | 2016-11-08 |
Update Frequency |
Irregular |
Temporal Coverage |
1980-01 to 2015-12 |
Spatial Coverage |
World |
Source | John Snow Labs; Global Health Data Exchange; |
Source License URL | |
Source License Requirements |
N/A |
Source Citation |
N/A |
Keywords | HIV AIDS Incidence, Global HIV Incidence, HIV Prevalence, Antiretroviral Therapy |
Other Titles | HIV AIDS Incidence Prevalence and Mortality, Estimated HIV Incidence Prevalence and Mortality Rates |
Data Fields
Name | Description | Type | Constraints |
---|---|---|---|
Location_Name | Location Name | string | - |
New_Infections_In_Thousands | Country-specific estimates of new HIV infections in thousands | number | level : Ratio |
New_Infections_UI95_Percentage | Country-specific estimates of new HIV infections in thousands (95% Uncertainty Interval) | string | - |
PLWH_In_Thousands | Counts of People Living With HIV/AIDS in thousands | number | level : Ratio |
PLWH_Percentage | Counts of People Living With HIV/AIDS in thousands (95% Uncertainty Interval) | string | - |
HIV_AIDS_Deaths_In_Thousands | Counts of HIV/AIDS deaths in thousands | number | level : Ratio |
HIV_AIDS_Deaths_Percentage | Counts of HIV/AIDS deaths in thousands (95% Uncertainty Interval) | string | - |
ART_Coverage_Per_100_PLWH | Antiretroviral Therapy coverage | number | level : Ratio |
ART_Coverage_Percentage | Antiretroviral Therapy coverage (% of people living with HIV) | string | - |
Age_Standardized_Incidence_Rate_ART | Antiretroviral Therapy Age-Standardized Incidence Rate | number | level : Ratio |
Age_Standardized_Incidence_Percentage | Antiretroviral Therapy Age-Standardized Incidence Percentage | string | - |
Age_Standardized_Prevalence_Rate_ART | Antiretroviral Therapy Age-Standardized Prevalence Rate | number | level : Ratio |
Age_Standardized_Prevalence_Percentage | Antiretroviral Therapy Age-Standardized Prevalence Percentage | string | - |
Age_Standardized_Mortality_Rate_ART | Antiretroviral Therapy Age-Standardized Mortality Rate | number | level : Ratio |
Age_Standardized_Mortality_Percentage | Antiretroviral Therapy Age-Standardized Mortality Percentage | string | - |
Data Preview
Location Name | New Infections In Thousands | New Infections UI95 Percentage | PLWH In Thousands | PLWH Percentage | HIV AIDS Deaths In Thousands | HIV AIDS Deaths Percentage | ART Coverage Per 100 PLWH | ART Coverage Percentage | Age Standardized Incidence Rate ART | Age Standardized Incidence Percentage | Age Standardized Prevalence Rate ART | Age Standardized Prevalence Percentage | Age Standardized Mortality Rate ART | Age Standardized Mortality Percentage |
Global | 2450.92 | 2236.13-2686.79 | 38802.5 | 37635.88-40371.67 | 1192.57 | 1131.11-1270.05 | 40.6 | 39.36-41.80 | -0.02 | -0.03--0.01 | 0.01 | 0.00-0.01 | -0.05 | -0.06--0.05 |
High SDI | 101.75 | 75.18-146.96 | 2204.18 | 1751.36-2799.27 | 33.51 | 31.96-35.43 | 51.49 | 43.90-57.55 | 0.01 | -0.01-0.04 | 0.01 | 0.00-0.02 | -0.01 | -0.02--0.01 |
High-middle SDI | 646.76 | 557.07-748.55 | 10421.94 | 9873.26-10989.83 | 240.15 | 224.08-259.28 | 48.01 | 45.99-50.13 | -0.02 | -0.03--0.01 | 0.01 | 0.01-0.02 | -0.05 | -0.06--0.05 |
Middle SDI | 298.33 | 238.18-394.91 | 4155.45 | 3616.14-5163.64 | 131.57 | 111.27-183.00 | 37.66 | 32.68-40.83 | 0.0 | -0.02-0.02 | 0.02 | 0.01-0.03 | -0.02 | -0.04--0.00 |
Low-middle SDI | 796.3 | 655.25-951.76 | 11783.44 | 11251.57-12472.97 | 408.87 | 368.10-457.42 | 35.48 | 33.62-37.52 | -0.01 | -0.03-0.01 | 0.0 | -0.01-0.00 | -0.06 | -0.07--0.06 |
Low SDI | 606.54 | 510.14-707.36 | 10213.36 | 9762.90-10684.37 | 377.68 | 350.43-408.08 | 37.89 | 35.93-39.79 | -0.05 | -0.07--0.03 | -0.01 | -0.02--0.01 | -0.08 | -0.09--0.07 |
High-income | 45.67 | 37.88-53.92 | 1660.18 | 1359.94-1997.98 | 13.95 | 13.79-14.11 | 66.91 | 64.76-69.43 | -0.01 | -0.02--0.00 | 0.0 | -0.01-0.00 | -0.06 | -0.06--0.05 |
High-income North America | 24.16 | 18.76-31.10 | 882.6 | 692.93-1136.45 | 7.89 | 7.79-7.98 | 69.86 | 66.81-73.51 | -0.02 | -0.04--0.01 | 0.0 | -0.01-0.00 | -0.07 | -0.07--0.07 |
Canada | 1.11 | 0.18-2.81 | 49.25 | 15.89-102.34 | 0.31 | 0.29-0.33 | 64.14 | 56.58-73.43 | -0.03 | -0.14-0.02 | -0.01 | -0.03-0.01 | -0.06 | -0.07--0.05 |
Greenland | 0.0 | 0.00-0.01 | 0.23 | 0.06-0.55 | 61.88 | 52.84-69.43 | -0.1 | -0.65--0.02 | -0.01 | -0.03-0.00 | -0.03 | -0.07-0.01 |